
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 3.260 | 3.260 | 0.000 |
Shares | 96.740 | 96.740 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 24.791 | 31.044 |
Price to Book | 5.142 | 6.921 |
Price to Sales | 3.340 | 5.303 |
Price to Cash Flow | 16.892 | 19.653 |
Dividend Yield | 0.725 | 0.696 |
5 Years Earnings Growth | 13.481 | 12.070 |
Name | Net % | Category Average |
---|---|---|
Technology | 28.490 | 37.708 |
Healthcare | 17.400 | 11.831 |
Consumer Cyclical | 15.040 | 14.203 |
Industrials | 13.760 | 7.674 |
Communication Services | 8.990 | 13.163 |
Financial Services | 8.630 | 10.990 |
Consumer Defensive | 4.360 | 3.886 |
Basic Materials | 1.830 | 1.951 |
Real Estate | 0.780 | 2.214 |
Energy | 0.710 | 1.747 |
Number of long holdings: 199
Number of short holdings: 0
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Microsoft | US5949181045 | 6.89 | 506.69 | -0.58% | |
Broadcom | US11135F1012 | 3.88 | 297.39 | -3.65% | |
Amazon.com | US0231351067 | 2.78 | 229.00 | -1.12% | |
Transdigm | US8936411003 | 2.65 | 1,398.88 | +0.06% | |
Meta Platforms | US30303M1027 | 2.61 | 738.70 | -1.65% | |
Alphabet A | US02079K3059 | 2.18 | 212.91 | +0.60% | |
Mastercard | US57636Q1040 | 2.11 | 595.29 | +0.81% | |
Abbott Labs | US0028241000 | 1.83 | 132.66 | +0.98% | |
UnitedHealth | US91324P1021 | 1.80 | 309.87 | +2.51% | |
Eli Lilly | US5324571083 | 1.72 | 732.58 | +0.08% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
LU1006075490 | 1.43B | -3.08 | 2.93 | 4.92 | ||
LU1481181243 | 597.38M | 14.65 | 11.37 | 7.20 | ||
LU1029763478 | 6.64B | -2.09 | 4.49 | 4.69 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review